Ebrantil is a drug from the group of selective alpha1 adrenergic blockers, used to treat arterial hypertension.
The drug is approved in the Russian Federation (official international name of the drug: Urapidil) and is used for the prevention of orthostatic hypotension during long-term use of antihypertensive drugs.